<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(3)</volume><submitter>Henrotin Y</submitter><journal>RMD open</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12352264</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial</pubmed_title><pmcid>PMC12352264</pmcid><pubmed_authors>Urbin-Choffray D</pubmed_authors><pubmed_authors>Dubuc J</pubmed_authors><pubmed_authors>von Eynatten M</pubmed_authors><pubmed_authors>Pap T</pubmed_authors><pubmed_authors>Badot V</pubmed_authors><pubmed_authors>Rau S</pubmed_authors><pubmed_authors>Henrotin Y</pubmed_authors><pubmed_authors>Lieten S</pubmed_authors><pubmed_authors>Johansen O</pubmed_authors><pubmed_authors>Brabants K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Oral enzyme combination therapy reduces systemic inflammation, urinary CTXII and pain in knee osteoarthritis: a proof-of-mechanism, randomised, crossover, double-blind, placebo-controlled trial</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-05-29T17:22:16.996Z</modification><creation>2026-04-08T05:36:01.249Z</creation></dates><accession>S-EPMC12352264</accession><cross_references/></HashMap>